Kezar Life Sciences, Inc. (KZR)
Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA.
Address
4000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO, CA 94080
Founded
2015
Number of Employees
58
Website
http://www.kezarlifesciences.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)